Aldeyra Therapeutics has disclosed positive results from the first of multiple Phase 3 studies of a new type of inflammation-fighting medicine the Lexington, MA, company has been testing in a variety of conditions.
Ben Einstein, co-founder and general partner of hardware-focused investor Bolt, says he has left the venture capital firm he started as his partner, Grace, enters chemotherapy for a cancer diagnosis.
“Through this gut-wrenching experience, the things I enjoy doing and that... Read more »
A decade ago, Kevin Conroy took the CEO job at Exact Sciences, a cancer diagnostic firm on the brink of death. Five years later, the FDA greenlit the company’s first product, Cologuard, which marked the first non-invasive, stool-based DNA... Read more »
The FDA has just made brexanolone (Zulresso) the first medicine approved specifically for post-partum depression, a potentially devastating disorder that afflicts roughly one in every seven new mothers in the U.S., according to the American Psychological Association
Now the drug’s owner,... Read more »
Flipside Crypto, a Boston startup developing analytics for cryptocurrencies, has landed its main metric onto CoinMarketCap and other financial websites including MarketWatch, TheStreet and Stocktwits, the company says.
Founded in 2017, Flipside says its Fundamental Crypto Asset Score—FCAS for short—rates the... Read more »
While all eyes in the biopharmaceutical world are currently trained on Bristol-Myers Squibb’s proposal to buy Celgene for $74 billion, it wasn’t that long ago that another company’s gaze was fixed on the Summit, NJ, drug maker.
In the early... Read more »
There’s robotics news, clinical research companies raising cash, and plenty of early-stage venture capital money moving in the Boston technology world this week. Read on for more:
John Maraganore, CEO of Alnylam Pharmaceuticals; Penny Heaton, CEO of the Bill & Melinda Gates Medical Research Institute; digital health leader Pear Therapeutics; and renowned women-in-science advocate and MIT professor emerita Nancy Hopkins. These outstanding leaders were among the winners of... Read more »
TriNetX, a Cambridge, MA, developer of data analytics software for clinical research, has raised $40 million in a Series D funding round led by Merck’s corporate venture capital fund, the company said.
The company’s analytics platform helps pharma companies detail the... Read more »
It’s been more than three years since the FDA approved salmon from AquaBounty Technologies, but debates about labels and other requirements have kept the genetically engineered fish from reaching dining plates. On Friday, the FDA removed the last regulatory hurdle standing... Read more »
Founder and CTO, Shopximity
Professor of Leadership, Emeritus at the Harvard Business School
Managing Director, Mobile Ecosystem
Chairman and CEO, Yumanity Therapeutics
Founder and CTO, Rethink Robotics
Partner, North Bridge Venture Partners
Professor of Genetics, Harvard Medical School
Co-Founder and CEO, SocMetrics, Inc.
CEO and Co-Founder, Tamr
Visiting Scholar, MIT